Zhao Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhao Zhou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jia Wang
Beijing University of Chemical Technology
2 shared publications - Qipeng Yuan
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, No.15, Beisanhuan East Road, Beijing 100029, China
2 shared publications - Xianglai Li
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China
2 shared publications - Xiaolin Shen
Beijing University of Chemical Technology
2 shared publications - Xinxiao Sun
Beijing University of Chemical Technology
2 shared publications - Yajun Yan
School of Chemical, Materials, and Biomedical Engineering, College of Engineering, The University of Georgia, Athens, USA
2 shared publications
Latest Publications
- Open Access
- 19 September 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Biosynthesis of plant hemostatic dencichine in Escherichia coli
Dencichine is a plant-derived nature product that has found various pharmacological applications. Currently, its natural biosynthetic pathway is still elusive, posing challenge to its heterologous biosynthesis. In this work, we design artificial pathways through retro-biosynthesis approaches and achieve de novo production of dencichine. First, biosynthesis of the two direct precursors L−2, 3-diaminopropionate and oxalyl-CoA is achieved by screening and integrating microbial enzymes. Second, the solubility of dencichine synthase, which is the last and only plant-derived pathway enzyme, is significantly improved by introducing 28 synonymous rare codons into the codon-optimized gene to slow down its translation rate. Last, the metabolic network is systematically engineered to direct the carbon flux to dencichine production, and the final titer reaches 1.29 g L−1 with a yield of 0.28 g g−1 glycerol. This work lays the foundation for sustainable production of dencichine and represents an example of how synthetic biology can be harnessed to generate unnatural pathways to produce a desired molecule.
- 19 September 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Open AccessBiosynthesis of plant hemostatic dencichine in Escherichia coli
Dencichine is a plant-derived nature product that has found various pharmacological applications. Currently, its natural biosynthetic pathway is still elusive, posing challenge to its heterologous biosynthesis. In this work, we design artificial pathways through retro-biosynthesis approaches and achieve de novo production of dencichine. First, biosynthesis of the two direct precursors L−2, 3-diaminopropionate and oxalyl-CoA is achieved by screening and integrating microbial enzymes. Second, the solubility of dencichine synthase, which is the last and only plant-derived pathway enzyme, is significantly improved by introducing 28 synonymous rare codons into the codon-optimized gene to slow down its translation rate. Last, the metabolic network is systematically engineered to direct the carbon flux to dencichine production, and the final titer reaches 1.29 g L−1 with a yield of 0.28 g g−1 glycerol. This work lays the foundation for sustainable production of dencichine and represents an example of how synthetic biology can be harnessed to generate unnatural pathways to produce a desired molecule.
- Open Access
- 23 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Design of stable and self-regulated microbial consortia for chemical synthesis
Microbial coculture engineering has emerged as a promising strategy for biomanufacturing. Stability and self-regulation pose a significant challenge for the generation of intrinsically robust cocultures for large-scale applications. Here, we introduce the use of multi-metabolite cross-feeding (MMCF) to establish a close correlation between the strains and the design rules for selecting the appropriate metabolic branches. This leads to an intrinicially stable two-strain coculture where the population composition and the product titer are insensitive to the initial inoculation ratios. With an intermediate-responsive biosensor, the population of the microbial coculture is autonomously balanced to minimize intermediate accumulation. This static-dynamic strategy is extendable to three-strain cocultures, as demonstrated with de novo biosynthesis of silybin/isosilybin. This strategy is generally applicable, paving the way to the industrial application of microbial cocultures.
- 23 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Open AccessDesign of stable and self-regulated microbial consortia for chemical synthesis
Microbial coculture engineering has emerged as a promising strategy for biomanufacturing. Stability and self-regulation pose a significant challenge for the generation of intrinsically robust cocultures for large-scale applications. Here, we introduce the use of multi-metabolite cross-feeding (MMCF) to establish a close correlation between the strains and the design rules for selecting the appropriate metabolic branches. This leads to an intrinicially stable two-strain coculture where the population composition and the product titer are insensitive to the initial inoculation ratios. With an intermediate-responsive biosensor, the population of the microbial coculture is autonomously balanced to minimize intermediate accumulation. This static-dynamic strategy is extendable to three-strain cocultures, as demonstrated with de novo biosynthesis of silybin/isosilybin. This strategy is generally applicable, paving the way to the industrial application of microbial cocultures.